receptor inhibitor
4.Objective To investigate the effects of gene transfer of a β-adrenergic receptor(β 2AR) kinase inhibitor (βARKct) on pulmonary β 2-adrenergic receptor and cyclic adenosine monophosphate(cAMP) following β 2AR agonist treatment in asthmaticmice, and to analyze the relationship between the routes of gene delivery and the changes of β 2AR and cAMP.
5.Urokinase-type plasminogen activator (uPA), its receptor (uPAR) and plasminogen activator inhibitor- 1(PAI-1) are part of the urokinase-type plasminogen activator system, playing an important role in degrading extracellular matrix and dissolution of the basement membrane.
8.In addition, HSC-T6 cells were preincubated for 60 min with U0126, an inhibitor of MAPK/ERK kinase, irbesartan, an AT-1 receptor blocker, N-acetylcysteine (NAC), antioxidant, angiotensin converting enzyme inhibitor (ACEI), or tumor necrosis factor α (TNFα) prior to exposure to AngⅡ or Aldo. Then the protein expression of phospho-P42/44 was measured by Western blotting.

